Moore Capital Management LP bought a new position in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 83,031 shares of the medical device company’s stock, valued at approximately $5,954,000.
Several other institutional investors and hedge funds have also made changes to their positions in COO. New York Life Investment Management LLC grew its holdings in shares of Cooper Companies by 0.6% in the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after purchasing an additional 158 shares during the last quarter. Root Financial Partners LLC lifted its holdings in Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares in the last quarter. Essential Partners LLC boosted its position in Cooper Companies by 23.4% in the 1st quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock valued at $62,000 after buying an additional 166 shares during the period. Allworth Financial LP boosted its position in Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after buying an additional 167 shares during the period. Finally, SJS Investment Consulting Inc. grew its stake in Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of brokerages have recently commented on COO. Mizuho set a $85.00 target price on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. Citigroup reissued a “neutral” rating and issued a $80.00 price objective (up from $76.00) on shares of Cooper Companies in a research note on Thursday, August 13th. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Stifel Nicolaus decreased their target price on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Finally, KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $81.64.
Cooper Companies Stock Performance
NASDAQ:COO opened at $71.17 on Monday. The firm has a 50-day simple moving average of $72.56 and a 200-day simple moving average of $70.81. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The firm has a market cap of $13.88 billion, a P/E ratio of 60.31, a P/E/G ratio of 1.86 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27.
Cooper Companies (NASDAQ:COO – Get Free Report) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period last year, the firm earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.
Cooper Companies Company Profile
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Read More
- Five stocks we like better than Cooper Companies
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
